Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAIL VITELLAS

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1023252293
CMS profile
1389615
Location
JOHNSON CITY, NY

General Payments · PY2018–2024

$5,496.03

  • Reported across 140 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$727.06

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $727.06 33

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,044.83 22
PY2019 $2,232.15 40
PY2020 $542.36 12
PY2021 $384.81 15
PY2022 $268.80 8
PY2023 $296.02 10
PY2024 $727.06 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $122.63 07/15/2024 Food and Beverage Undisputed 01/23/2026 1124801156 CMS
Abbott Laboratories $12.24 10/01/2024 Food and Beverage Undisputed 01/23/2026 1124801158 CMS
Abbott Laboratories $5.52 12/24/2024 Food and Beverage Undisputed 01/23/2026 1124801160 CMS
Boston Scientific Corporation $18.71 11/04/2024 Food and Beverage Undisputed 01/23/2026 1092299733 CMS
Edwards Lifesciences Corporation $127.48 12/04/2024 Food and Beverage Undisputed 01/23/2026 1138809775 CMS
Janssen Pharmaceuticals, Inc $14.62 02/09/2024 Food and Beverage Undisputed 01/23/2026 1078110844 CMS
Lexicon Pharmaceuticals, Inc. $24.12 03/21/2024 Food and Beverage Undisputed 01/23/2026 1081713818 CMS
Lexicon Pharmaceuticals, Inc. $21.12 06/11/2024 Food and Beverage Undisputed 01/23/2026 1081713816 CMS
Novartis Pharmaceuticals Corporation $11.60 01/16/2024 Food and Beverage Undisputed 01/23/2026 1087421226 CMS
Novartis Pharmaceuticals Corporation $9.38 01/16/2024 Food and Beverage Undisputed 01/23/2026 1087421232 CMS
Novartis Pharmaceuticals Corporation $11.34 01/24/2024 Food and Beverage Undisputed 01/23/2026 1087421228 CMS
Novartis Pharmaceuticals Corporation $9.01 01/24/2024 Food and Beverage Undisputed 01/23/2026 1087421234 CMS
Novartis Pharmaceuticals Corporation $9.38 02/14/2024 Food and Beverage Undisputed 01/23/2026 1087421230 CMS
Novartis Pharmaceuticals Corporation $12.99 02/14/2024 Food and Beverage Undisputed 01/23/2026 1087421236 CMS
Novartis Pharmaceuticals Corporation $10.61 03/06/2024 Food and Beverage Undisputed 01/23/2026 1087421248 CMS
Novartis Pharmaceuticals Corporation $11.04 03/06/2024 Food and Beverage Undisputed 01/23/2026 1087421250 CMS
Novartis Pharmaceuticals Corporation $13.14 04/01/2024 Food and Beverage Undisputed 01/23/2026 1087421254 CMS
Novartis Pharmaceuticals Corporation $11.78 04/01/2024 Food and Beverage Undisputed 01/23/2026 1087421256 CMS
Novartis Pharmaceuticals Corporation $9.35 04/30/2024 Food and Beverage Undisputed 01/23/2026 1087421260 CMS
Novartis Pharmaceuticals Corporation $9.94 04/30/2024 Food and Beverage Undisputed 01/23/2026 1087421262 CMS
Novartis Pharmaceuticals Corporation $12.86 05/20/2024 Food and Beverage Undisputed 01/23/2026 1087421266 CMS
Novartis Pharmaceuticals Corporation $14.33 05/20/2024 Food and Beverage Undisputed 01/23/2026 1087421272 CMS
Novartis Pharmaceuticals Corporation $13.79 05/28/2024 Food and Beverage Undisputed 01/23/2026 1087421268 CMS
Novartis Pharmaceuticals Corporation $11.12 05/28/2024 Food and Beverage Undisputed 01/23/2026 1087421274 CMS
Novartis Pharmaceuticals Corporation $13.95 06/10/2024 Food and Beverage Undisputed 01/23/2026 1087421270 CMS
Novartis Pharmaceuticals Corporation $11.31 06/10/2024 Food and Beverage Undisputed 01/23/2026 1087421276 CMS
Novartis Pharmaceuticals Corporation $10.62 07/29/2024 Food and Beverage Undisputed 01/23/2026 1087421280 CMS
Novartis Pharmaceuticals Corporation $11.43 07/29/2024 Food and Beverage Undisputed 01/23/2026 1087421282 CMS
Novartis Pharmaceuticals Corporation $10.69 08/28/2024 Food and Beverage Undisputed 01/23/2026 1087421286 CMS
Novartis Pharmaceuticals Corporation $12.05 10/21/2024 Food and Beverage Undisputed 01/23/2026 1087421292 CMS
Novartis Pharmaceuticals Corporation $11.20 10/21/2024 Food and Beverage Undisputed 01/23/2026 1087421294 CMS
Novartis Pharmaceuticals Corporation $10.24 12/16/2024 Food and Beverage Undisputed 01/23/2026 1087421298 CMS
Recor Medical Inc $107.47 10/09/2024 Food and Beverage Undisputed 01/23/2026 1127687903 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.